Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 4 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Recs

1
Player Avatar SpartanMAC (20.58) Submitted: 12/27/2010 4:35:02 PM : Outperform Start Price: $8.59 TRIB Score: +17.98

Found this off of a modified GB screen (ROA > 25%, Earnings Yield >10%. Also, earnings quality looks good and projected growth is solid.

Featured Broker Partners


Advertisement